Optimizing electronic health record prompts with behavioral economics to improve prescribing for older adults
优化电子健康记录促进行为经济学改善老年人处方
基本信息
- 批准号:10245079
- 负责人:
- 金额:$ 70.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse drug eventAdverse eventAlternative TherapiesAnti-CholinergicsAntipsychotic AgentsAwarenessBenzodiazepinesCaregiversClinicalCluster randomized trialConfusionDataDropsDrug PrescriptionsDrug usageEffectivenessElderlyElectronic Health RecordEnsureEnvironmentEvaluationFocus GroupsFractureGeriatricsGuidelinesHealthHealthcare SystemsHospitalizationImageryInsurance CarriersInterventionMethodsOutcomeOutpatientsPatient-Focused OutcomesPatientsPharmaceutical PreparationsPhysiciansPractice GuidelinesProviderRandomizedRandomized Controlled TrialsResearchResearch DesignRiskScienceSedation procedureStructureSystemTechniquesTestingarmbasebehavior changebehavioral economicsclinical decision-makingclinically significantdesigneffectiveness evaluationeffectiveness validationelectronic datafallshigh riskhypnoticimprovedinnovationinsightmultidisciplinarynovelpressureprimary outcomeprovider behaviorrandomized trialsecondary outcomesedativesocial normsuccesssupport toolstooltreatment as usualtrial designusability
项目摘要
Prescribing of potentially unsafe medications for older adults is extremely common; benzodiazepines,
antipsychotics, anticholinergics, and sedative hypnotics are four key drug classes frequently implicated in
adverse health consequences for vulnerable older adults, such as confusion or sedation, leading to
hospitalizations, falls, and fractures. Fortunately, most of these consequences are preventable. Physicians’
lack of awareness of alternatives, ambiguous practice guidelines, and perceived pressure from patients or
caregivers are among the reasons why these drugs are used more than might be optimal. Reducing
inappropriate use of these drugs may be achieved through decision support tools for providers that are
embedded in electronic health record (EHR) systems. While EHR strategies are widely used to support the
informational needs of providers, these tools have demonstrated only modest effectiveness at improving
prescribing. The effectiveness of these tools could be enhanced by leveraging principles of behavioral
economics and related sciences. In specific, three behavioral economic principles, such as salience effects,
social norming, and default bias, have successfully changed behavior in other settings but have had very
limited application in EHRs and, more specifically, for prescribing in older adults.
To this end, we propose three cluster randomized controlled trials of novel EHR decision support tools that
seek to reduce inappropriate prescribing for these drug classes and their associated adverse drug events and
health outcomes. This proposal builds on many years of research by our group on interventions to engage
providers and patients in clinical-decision making, behavior change, and evaluating novel interventions in real-
world delivery systems. The EHR decision support tools will be designed using promising behavioral economic
principles such as salience effects, social norming, and default bias.
The specific aims of this study are to: (1) design and pilot test multiple EHR decision support tools
constructed using behavioral economics principles; (2) rapidly identify the potential effectiveness of numerous
EHR tools at reducing inappropriate prescribing using a novel randomized adaptive design; (3) examine
whether these most potentially promising EHR tools from Aim 2 reduce inappropriate prescribing and adverse
drug events when using a randomized parallel group trial; and (4) evaluate the effectiveness of the EHR tools
in a different clinical environment. Using rigorous randomized designs, we have proposed a pragmatic and
scalable approach to optimizing and evaluating EHR tools aimed at provider behavior change for prescribing
for older adults. We will also be able to rigorously test a large number of EHR tools as well as replicate and
validate the effectiveness of the best performing tools in a different healthcare system. The expected overall
impact of this innovative proposal is that it will fundamentally advance how behavioral economics can be used
to optimize decision support to reduce inappropriate prescribing and ultimately improve patient outcomes.
为老年人开具潜在不安全药物的情况极为常见;苯二氮卓类药物,
抗精神病药、抗胆碱能药和镇静催眠药是常见的四种主要药物类别
对脆弱的老年人造成不利的健康后果,例如混乱或镇静,导致
住院、跌倒和骨折。幸运的是,大多数这些后果是可以预防的。医生的
缺乏对替代方案的认识、模棱两可的实践指南以及来自患者或患者的压力
护理人员是这些药物使用量超过最佳用量的原因之一。减少
这些药物的不当使用可以通过为提供者提供的决策支持工具来实现,这些工具是
嵌入电子健康记录(EHR)系统中。虽然 EHR 策略被广泛用于支持
供应商的信息需求,这些工具在改善
开处方。通过利用行为原则可以提高这些工具的有效性
经济学及相关科学。具体来说,三个行为经济学原理,例如显着效应,
社会规范和默认偏见已经成功地改变了其他环境中的行为,但也产生了很大的影响。
在电子病历中的应用有限,更具体地说,在老年人处方中的应用有限。
为此,我们提出了三项新型 EHR 决策支持工具的集群随机对照试验,
寻求减少对这些药物类别的不当处方及其相关的药物不良事件,
健康结果。该提案建立在我们小组多年关于干预措施的研究基础上
提供者和患者进行临床决策、行为改变以及评估真实的新干预措施
世界运输系统。 EHR 决策支持工具将使用有前途的行为经济学来设计
显着效应、社会规范和默认偏见等原则。
本研究的具体目标是:(1)设计并试点测试多种 EHR 决策支持工具
使用行为经济学原理构建; (2) 快速识别众多潜在的有效性
使用新颖的随机自适应设计减少不当处方的 EHR 工具; (3)检查
目标 2 中这些最有潜力的 EHR 工具是否可以减少不当处方和不良处方
使用随机平行组试验时发生的药物事件; (4) 评估 EHR 工具的有效性
在不同的临床环境中。通过严格的随机设计,我们提出了一种务实且
优化和评估 EHR 工具的可扩展方法,旨在改变提供者的处方行为
对于老年人。我们还将能够严格测试大量 EHR 工具以及复制和
验证不同医疗保健系统中性能最佳的工具的有效性。预期整体
这一创新提案的影响在于,它将从根本上推进行为经济学的应用
优化决策支持,减少不当处方,最终改善患者治疗效果。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rationale and design of the Novel Uses of adaptive Designs to Guide provider Engagement in Electronic Health Records (NUDGE-EHR) pragmatic adaptive randomized trial: a trial protocol.
- DOI:10.1186/s13012-020-01078-9
- 发表时间:2021-01-07
- 期刊:
- 影响因子:0
- 作者:Lauffenburger JC;Isaac T;Trippa L;Keller P;Robertson T;Glynn RJ;Sequist TD;Kim DH;Fontanet CP;Castonguay EWB;Haff N;Barlev RA;Mahesri M;Gopalakrishnan C;Choudhry NK
- 通讯作者:Choudhry NK
Designing and conducting adaptive trials to evaluate interventions in health services and implementation research: practical considerations.
设计和进行适应性试验以评估卫生服务干预措施和实施研究:实际考虑。
- DOI:10.1136/bmjmed-2022-000158
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Lauffenburger,JulieC;Choudhry,NiteeshK;Russo,Massimiliano;Glynn,RobertJ;Ventz,Steffen;Trippa,Lorenzo
- 通讯作者:Trippa,Lorenzo
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Niteesh K Choudhry其他文献
Niteesh K Choudhry的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Niteesh K Choudhry', 18)}}的其他基金
Analysis and visualization of longitudinal assessments of clinical, functional and psychosocial state of AD patients from the Massachusetts home care program
对马萨诸塞州家庭护理项目 AD 患者的临床、功能和心理社会状态的纵向评估进行分析和可视化
- 批准号:
10756631 - 财政年份:2021
- 资助金额:
$ 70.15万 - 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC)
- 批准号:
10491782 - 财政年份:2021
- 资助金额:
$ 70.15万 - 项目类别:
Al-Supported In-Home Brain Assessments for Older Adults and Persons with Alzheimer's Disease
Al 支持的针对老年人和阿尔茨海默病患者的家庭大脑评估
- 批准号:
10755044 - 财政年份:2021
- 资助金额:
$ 70.15万 - 项目类别:
Validating novel sleep sensors and devices in older adults with Alzheimer's disease
在患有阿尔茨海默病的老年人中验证新型睡眠传感器和设备
- 批准号:
10756674 - 财政年份:2021
- 资助金额:
$ 70.15万 - 项目类别:
Creation of a technology-ready cohort for patients with Alzheimer's disease and related dementias and their caregivers
为阿尔茨海默病和相关痴呆症患者及其护理人员创建技术就绪队列
- 批准号:
10782660 - 财政年份:2021
- 资助金额:
$ 70.15万 - 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC)
- 批准号:
10675671 - 财政年份:2021
- 资助金额:
$ 70.15万 - 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC)
- 批准号:
10274688 - 财政年份:2021
- 资助金额:
$ 70.15万 - 项目类别:
Passive Monitoring of Walking Cadence as a Novel Tool for Aging and Cognitive Health Assessment
步行节奏的被动监测作为衰老和认知健康评估的新工具
- 批准号:
10755452 - 财政年份:2021
- 资助金额:
$ 70.15万 - 项目类别:
Leveraging electronic health record tools to reduce health disparities for patients with uncontrolled hypertension
利用电子健康记录工具减少未受控制的高血压患者的健康差异
- 批准号:
10542667 - 财政年份:2020
- 资助金额:
$ 70.15万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 70.15万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 70.15万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 70.15万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 70.15万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 70.15万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 70.15万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 70.15万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 70.15万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 70.15万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 70.15万 - 项目类别:














{{item.name}}会员




